Strides Pharma gets USFDA inspection report for Alathur unit with no adverse observations

Strides Pharma gets USFDA inspection report for Alathur unit with no adverse observations It has received the establishment inspection report (EIR), thereby confirming the successful closure of the inspections, the company added.

No comments:

Post a Comment